RT by @EU_Health: Good to meet journalists from across Europe today to discuss biotechnology & #BiotechAct and what it can mean for our future.

Faster clinical trials, better access to finance & stronger biomanufacturing capacity can help innovation stay, grow and deliver for patients in Europe.
---
https://nitter.net/OliverVarhelyi/status/2067661673733693696#m

RT by @EU_Health: Today’s #EPSCO showed real delivery on Europe’s health agenda.

Thank you to Minister @NeophytosGC and @CY2026EU for driving complex files forward with speed and ambition - including for your work on the #CriticalMedicinesAct and #BiotechAct.

Watch my press remarks below ⬇️

Today’s #EPSCO showed real delivery on Europe’s health agenda.

Thank you to Minister @NeophytosGC and @CY2026EU for driving complex files forward with speed and ambition - including for your work on the #CriticalMedicinesAct and #BiotechAct.

Watch my press remarks below ⬇️

Video
---
https://nitter.net/OliverVarhelyi/status/2066961925804556637#m

RT by @europainitalia: Alzheimer’s affects memory, identity & independence with a huge impact on patients, families & caregivers.

In my message at MindShift in 🇮🇹, I underlined 🇪🇺 support for prevention, diagnosis & care from brain health research to the #SafeHeartsPlan, #medicaldevices & #BiotechAct.

Alzheimer’s affects memory, identity & independence with a huge impact on patients, families & caregivers.

In my message at MindShift in 🇮🇹, I underlined 🇪🇺 support for prevention, diagnosis & care from brain health research to the #SafeHeartsPlan, #medicaldevices & #BiotechAct.

Video
---
https://nitter.net/OliverVarhelyi/status/2066421388940824993#m

EU Parliament heads to December plenary to vote on the Biotech Act – a one‑stop rule book for biotech.

Key insight: it balances faster approvals with tighter safety checks and ethics oversight.

- Unified EU framework
- Faster market access
- Strong public‑rights safeguards

Will it really protect people while fueling innovation? Time will tell.

#BiotechAct #EUpolicy #DecentralisedTech #PrivacyFirst #InnovationEthics

🔗 https://news.google.com/rss/articles/CBMimwFBVV95cUxOVmN2UHh5N2cybnRTUlpMSm5ZXzZGQmpJc1VGbGNlWG84NnUyYnpLZnpva0loYWVfSGo5eHZjM2NoTXZvWUJldzNYTHpHWGIxYldKek53NVR1ald6aW80eE4ydnBvVDhsNWQ0d3UyR1pweHZzX2R5U0FMVFQwZnNCLXZjUXFZX3ZsTWV0STZ2azl0a0kzYUNzS1ZyYw?oc=5

.@OliverVarhelyi: Attraverso il #BiotechAct e l'Omnibus sulla sicurezza degli animali e dei mangimi, stiamo rafforzando il ruolo dell'EFSA - per accelerare le valutazioni mantenendo gli standard più elevati.

Oliver Varhelyi (@OliverVarhelyi)

Through the #BiotechAct and Food & Feed Safety Omnibus, we are strengthening EFSA’s role - to speed up assessments while maintaining the highest standards.

— https://nitter.net/OliverVarhelyi/status/2049470044820685202#m
---
https://nitter.net/europainitalia/status/2049479739002224840#m

Europe's biotech gap must close.

We back the @EU_Commission #BioTechAct and call for:
🔬 an ecosystem linking research & production;
🔬 permanent investment tools;
🔬 a central role for the European Medicines Agency;
🔬 stronger clinical trials for all patients.

Europe's biotech gap must close.

We back the @EU_Commission #BioTechAct and call for:
🔬 an ecosystem linking research & production;
🔬 permanent investment tools;
🔬 a central role for the Europ...
---
https://nitter.net/EU_EESC/status/2044317298996203664#m

RT by @EU_Health: Today, I met with @EORTC representatives: non-commercial clinical trials are instrumental to optimise treatments, improve outcomes, and support accessible, tailored cancer care, enhancing patients’ quality of life.

The #BiotechAct and #PharmaReform will help make this easier.
---
https://nitter.net/OliverVarhelyi/status/2023744840513564724#m